Document Detail

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma.
MedLine Citation:
PMID:  22940405     Owner:  NLM     Status:  MEDLINE    
Nonmalignant cutaneous findings associated with the use of vemurafenib have only recently been described in the literature. Patients receiving vemurafenib have exhibited cutaneous reactions including prominent follicular plugging, hand-foot skin reaction, exuberant seborrheic dermatitis-like hyperkeratosis of the face, keratosis pilaris, and diffuse spiny follicular hyperkeratosis. Many of these nonmalignant cutaneous findings are associated with abnormal follicular keratinization thought to be secondary to abnormal signaling of the mitogen-activated protein kinase pathway that occurs with the use of BRAF inhibitors. Whether underlying Ras mutations affect this abnormal signaling as in malignant lesions is still unknown. Different therapeutic options exist for these patients that may result in significant improvement in some of these nonmalignant cutaneous findings. Conservative treatment should focus on topical therapies such as topical retinoids or topical steroids. However, systemic therapies such as concomitant oral retinoids or MEK inhibitors should be considered for more severe or refractory cutaneous findings.
Kevin P Boyd; Bethaney Vincent; Aleodor Andea; R Martin Conry; Lauren C Hughey
Related Documents :
3352445 - Laryngeal/voice findings in patients with velopharyngeal dysfunction.
9115605 - Early intragastric feeding of seriously burned and long-term ventilated patients: a rev...
7936225 - Anosognosia for hemiplegia: an electrophysiologic investigation of the feed-forward hyp...
25267215 - Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty...
10930815 - Lung nodular lesions in heart transplant recipients.
12930375 - T cell receptor vb repertoire diversity in patients with immune thrombocytopenia follow...
Publication Detail:
Type:  Journal Article; Review     Date:  2012-08-30
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  67     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-19     Completed Date:  2013-01-22     Revised Date:  2014-04-08    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1375-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Eruptions / etiology*,  therapy
Indoles / adverse effects*,  therapeutic use
Melanoma / drug therapy*,  secondary*
Skin Neoplasms / drug therapy*,  pathology*
Sulfonamides / adverse effects*,  therapeutic use
Reg. No./Substance:
0/Indoles; 0/PLX4032; 0/Sulfonamides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dermatoscopy of hair shaft disorders.
Next Document:  Cutaneous gnathostomiasis: Report of 6 cases with emphasis on histopathological demonstration of the...